Sanofi and Regeneron Announce CHMP Recommends European Approval of Praluent(®)
(alirocumab) for the Treatment of Hypercholesterolemia
Paris and Tarrytown, New York - July 24, 2015 - Sanofi and Regeneron
Pharmaceuticals, Inc. announced today that the European M ...
↧